As of 2024-09-13, the Relative Valuation of Pfizer Inc (PFE) is (1.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 29.16 USD, the upside of Pfizer Inc based on Relative Valuation is -106.6%.
The range of the Relative Valuation is (8.79) - 9.95 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.2x - 29.9x | 29.6x |
| Forward P/E multiples | 22.8x - 31.8x | 31.0x |
| Fair Price | (8.79) - 9.95 | (1.93) |
| Upside | -130.2% - -65.9% | -106.6% |
| Date | P/E |
| 2024-09-12 | -63.68 |
| 2024-09-11 | -64.77 |
| 2024-09-10 | -64.94 |
| 2024-09-09 | -64.22 |
| 2024-09-06 | -62.37 |
| 2024-09-05 | -62.26 |
| 2024-09-04 | -62.00 |
| 2024-09-03 | -61.80 |
| 2024-08-30 | -63.35 |
| 2024-08-29 | -62.72 |
| 2024-08-28 | -62.78 |
| 2024-08-27 | -62.93 |
| 2024-08-26 | -63.15 |
| 2024-08-23 | -63.11 |
| 2024-08-22 | -62.85 |
| 2024-08-21 | -63.39 |
| 2024-08-20 | -63.11 |
| 2024-08-19 | -62.89 |
| 2024-08-16 | -61.80 |
| 2024-08-15 | -62.69 |
| 2024-08-14 | -63.07 |
| 2024-08-13 | -63.00 |
| 2024-08-12 | -62.13 |
| 2024-08-09 | -62.34 |
| 2024-08-08 | -62.80 |
| 2024-08-07 | -63.00 |
| 2024-08-06 | -64.03 |
| 2024-08-05 | -64.94 |
| 2024-08-02 | -66.45 |
| 2024-08-01 | -66.93 |
| 2024-07-31 | -66.69 |
| 2024-07-30 | -68.55 |
| 2024-07-29 | -67.08 |
| 2024-07-26 | -67.19 |
| 2024-07-25 | -65.90 |
| 2024-07-24 | -65.47 |
| 2024-07-23 | -64.42 |
| 2024-07-22 | -64.64 |
| 2024-07-19 | -65.45 |
| 2024-07-18 | -64.88 |
| 2024-07-17 | -65.58 |
| 2024-07-16 | -64.42 |
| 2024-07-15 | -63.55 |
| 2024-07-12 | -63.15 |
| 2024-07-11 | -62.58 |
| 2024-07-10 | -61.91 |
| 2024-07-09 | -60.53 |
| 2024-07-08 | -60.99 |
| 2024-07-05 | -61.25 |
| 2024-07-03 | -60.49 |